Cost-Benefit Analysis Explained: Usage, Advantages, and Drawbacks

Discover how cost-benefit analysis helps determine project viability by balancing financial and intangible factors, its ...
The American Journal of Managed Care

Dr William Padula Explores Applications of Cost-Effectiveness Analysis in Health Care

William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, discusses the benefits ...
The American Journal of Managed Care

Cost-Effectiveness of Integrated Behavioral Health for Depression, Anxiety, and Chronic Pain

Integrating behavioral health into primary care is cost-effective from the US health system perspective, with reduced prescription drug expenses being a key driver of these savings. Objective: To ...
Health Affairs

The Case For Including Dynamic Drug Pricing In Cost-Effectiveness Analyses Under The IRA

This commentary argues that practitioners of cost-effectiveness analyses should incorporate dynamic drug pricing into formal cost-effectiveness analyses (CEAs). For reasons we discuss, doing so will ...
STAT

Cost-effectiveness of health interventions may be perpetuating health disparities. Here’s how to fix that

As an epidemiologist and physician, I’ve long been concerned about how health interventions for marginalized communities are evaluated. A new study explores that concern and offers some solutions for ...
ascopubs.org

Cost-effectiveness analysis (CEA) of seven treatment regimens in metastatic hormone-sensitive prostate cancer (mHSPC): A public payer perspective using network meta-analysis.

Baseline circulating tumor cell (CTC) count as a prognostic marker of overall survival (OS) in metastatic hormone sensitive prostate cancer (mHSPC): Results from SWOG S1216, a phase III randomized ...
ascopubs.org

Cost-Effectiveness of eRAPID eHealth Intervention for Symptom Management During Chemotherapy

Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102 A randomized controlled trial ...
Healio

Analysis: Price of hemophilia A therapy would have to drop nearly 60% to be cost-effective

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...